Annelies H Boekhout

6PUBLICATIONS
32CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Palliative carePredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 30, 2025
Exploring the Impact of the Multimodal CAPABLE eHealth Intervention on Health-Related Quality of Life in Patients With Melanoma Undergoing Immune-Checkpoint Inhibition: Prospective Pilot Study.

Itske Fraterman, Lucia Sacchi, Henk Mallo

|Oct 11, 2023
An eHealth App (CAPABLE) Providing Symptom Monitoring, Well-Being Interventions, and Educational Material for Patients With Melanoma Treated With Immune Checkpoint Inhibitors: Protocol for an Exploratory Intervention Trial.

Itske Fraterman, Barbara M Wollersheim, Valentina Tibollo

|May 19, 2022
Exploring supportive care and information needs through a proposed eHealth application among melanoma patients undergoing systemic therapy: a qualitative study.

Itske Fraterman, Savannah L C Glaser, Sofie Wilgenhof

|Sep 14, 2020
Health-related quality of life of long-term advanced melanoma survivors treated with anti-CTLA-4 immune checkpoint inhibition compared to matched controls.

A H Boekhout, A Rogiers, K Jozwiak

|Jul 10, 2020
Design of the PROstate cancer follow-up care in Secondary and Primary hEalth Care study (PROSPEC): a randomized controlled trial to evaluate the effectiveness of primary care-based follow-up of localized prostate cancer survivors.

Barbara M Wollersheim, Kristel M van Asselt, Henk G van der Poel

|Nov 28, 2019
The risk of developing cardiovascular disease is increased for patients with prostate cancer who are pharmaceutically treated for depression.

Barbara M Wollersheim, Annelies H Boekhout, Henk G van der Poel

Pageof 1

Frequent Collaborators

3 joint publications

Lonneke V van de Poll-Franse

2 joint publications

Itske Fraterman

2 joint publications

Barbara M Wollersheim

2 joint publications

Valentina Tibollo